24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
| No Data For This Reporting Period. | |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
IL 2 FORCE FIELD BENCHMARKING |
40.82% |
|
IL 2 DYNAMICS SIMULATIONS |
20.41% |
|
ANTIBODY DYNAMICS SIMULATION |
20.41% |
|
ENZYME DYNAMICS |
18.37% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
24.95% |
|
ANTIBODY DYNAMICS SIMULATION |
20.96% |
|
IL 2 FORCE FIELD BENCHMARKING |
13.13% |
|
ANTIBODY AFFINITY MATURATION |
9.37% |
|
ANTIBODY DYNAMICS |
7.5% |
|
IL 2 DYNAMICS SIMULATIONS |
6.73% |
|
IL 2 RECEPTOR DYNAMICS |
4.69% |
|
PARKINSONS |
3.54% |
|
ALZHEIMERS |
2.7% |
|
UNSPECIFIED |
1.72% |
|
STP6 SUGAR TRANSPORT |
1.41% |
|
CANCER |
.82% |
|
ATSTP10 TRANSPORT MECHANISM |
.56% |
|
MEMBRANE TRANSPORT |
.51% |
|
SUCROSE TRANSPORT PLANTS |
.49% |
|
PLANT SUCROSE TRANSPORT |
.46% |
|
ATSTP10 SUCROSE TRANSPORT |
.45% |